

The synergy between a penicillin-type antibiotic, a beta-lactamase inhibitor, and a probiotic is a significant milestone in modern medicine. Amoxycillin Clavulanate & Lactic Acid Bacillus represents a triple-action approach to infection management. While Amoxycillin Clavulanate & Lactic Acid Bacillus works to destroy the bacterial cell wall, Clavulanic Acid protects it from enzymatic degradation, and Lactic Acid Bacillus ensures that the patient’s microbiome remains balanced during the treatment course.
This combination is particularly effective against organisms that have developed resistance to Amoxycillin Clavulanate & Lactic Acid Bacillusalone. By adding Lactic Acid Bacillus, healthcare providers can offer a “complete” prescription that addresses both the infection and the patient’s post-treatment recovery.
Angoclav-625 LB Tablets is a premium anti-infective offering from Aingo Pharma, designed for maximum bioavailability and patient compliance. We understand that effective therapy is not just about killing bacteria; it is about holistic patient care.
Angoclav-625 LB is manufactured in state-of-the-art facilities following strict WHO-GMP guidelines. This ensures that every tablet delivers the precise dosage of Amoxycillin Clavulanate & Lactic Acid Bacillus required to combat moderate to severe respiratory, urinary, and skin infections

To understand why Amoxycillin Clavulanate & Lactic Acid Bacillus is so effective, we must look at the pharmacodynamics of its components:
The combined action ofAmoxycillin Clavulanate & Lactic Acid Bacillus ensures that the drug remains potent even against resistant strains of Staphylococcus aureus, Haemophilus influenzae, and Klebsiella.
The clinical benefits of prescribing Amoxycillin Clavulanate & Lactic Acid Bacillus over standard antibiotics are numerous:
The “LB” in Angoclav-625 LB stands for Lactic Acid Bacillus, a critical component for modern antibiotic prescribing. Antibiotics, particularly broad-spectrum ones like Amoxycillin, can cause a massive shift in the intestinal microbiota. This often leads to secondary infections like Clostridium difficile or simply chronic digestive discomfort.
By incorporating Amoxycillin Clavulanate & Lactic Acid Bacillus, Aingo Pharma provides a protective shield for the digestive tract. These spores germinate in the intestine, producing lactic acid which inhibits the growth of pathogenic bacteria and promotes a healthy acidic environment for beneficial flora.
Amoxycillin Clavulanate & Lactic Acid Bacillus is indicated for a variety of clinical conditions, including:
The presence of Amoxycillin Clavulanate & Lactic Acid Bacillus in Angoclav-625 LB makes it an ideal choice for pediatric and geriatric patients who are more susceptible to the gastrointestinal side effects of antibiotics.
Why choose combination therapy? The logic behind Amoxycillin Clavulanate & Lactic Acid Bacillus is centered on the concept of “synergistic protection.”
Standard Amoxycillin is often ineffective in modern clinical settings due to the prevalence of enzyme-mediated resistance. Furthermore, prescribing standard Amoxycillin-clavulanate without a probiotic often leads to treatment discontinuation because of diarrhea. The combination of Amoxycillin Clavulanate & Lactic Acid Bacillus solves both problems simultaneously: ensuring the antibiotic works and ensuring the patient can tolerate it.
For Angoclav-625 LB Tablets, the dosage is typically determined by the severity of the infection and the patient’s weight/age.
While Amoxycillin Clavulanate & Lactic Acid Bacillus is generally well-tolerated, certain precautions should be observed:
The addition of the probiotic in the Amoxycillin Clavulanate & Lactic Acid Bacillus formula specifically targets and reduces the most common side effect: diarrhea.
Aingo Pharma has built a reputation on quality, transparency, and innovation. Healthcare professionals and distributors prefer Angoclav-625 LB Tablets because:
The global market for Amoxycillin Clavulanate & Lactic Acid Bacillus is witnessing a significant surge. This is driven by the increasing awareness of gut health and the rising incidence of beta-lactamase-producing bacterial strains.
Pharma distributors and franchise partners are increasingly looking for “LB” variants because they offer a competitive edge. Prescribing Amoxycillin Clavulanate & Lactic Acid Bacillus reduces the need for ancillary medications to treat diarrhea, making it a cost-effective and clinically superior choice for the patient.

Frequently Asked Questions:
Angoclav-625 LB is a combination antibiotic and probiotic tablet containing Amoxycillin Clavulanate & Lactic Acid Bacillus . It is used to treat a variety of bacterial infections, including respiratory tract infections, urinary tract infections, skin infections, and dental abscesses.
Antibiotics often disrupt the natural balance of gut bacteria, which can lead to diarrhea or indigestion. The inclusion of Lactic Acid Bacillus in this formulation helps restore healthy gut flora, preventing Antibiotic-Associated Diarrhea (AAD).
No. Amoxycillin Clavulanate & Lactic Acid Bacillus is only effective against bacterial infections. It does not work for viral infections such as the common cold, flu, or COVID-19.
Some bacteria produce an enzyme called beta-lactamase that destroys Amoxycillin. Clavulanic Acid inhibits this enzyme, allowing the Amoxycillin to work effectively against resistant strains of bacteria.
It is recommended to take the tablet at the start of a meal. This enhances the absorption of the medicine and minimizes potential stomach upset.
No. You must complete the full course of Amoxycillin Clavulanate & Lactic Acid Bacillus as prescribed by your doctor. Stopping early can allow the remaining bacteria to multiply, leading to a relapse or the development of antibiotic resistance.
While there are no major food restrictions, it is generally advised to avoid excessive alcohol consumption while on antibiotics, as it may increase the risk of side effects like dizziness or stomach upset.
This medication should only be used during pregnancy or lactation if clearly needed and specifically prescribed by a healthcare provider. Always consult your doctor before starting therapy.
Take the missed dose as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed one and continue with your regular cycle. Do not take a double dose to make up for a missed one.
Aingo Pharma ensures the highest standards of purity and stability. Our Amoxycillin Clavulanate & Lactic Acid Bacillus formulation uses 60 million spores of Lactic Acid Bacillus to ensure maximum gut protection, manufactured in a WHO-GMP certified facility.
Conclusion
The combination ofAmoxycillin Clavulanate & Lactic Acid Bacillus represents the pinnacle of broad-spectrum antibiotic therapy. By effectively tackling resistant bacteria while simultaneously safeguarding the patient’s internal ecosystem, Angoclav-625 LB Tablets by Aingo Pharma stands as a testament to advanced pharmaceutical care.
For healthcare providers, it offers peace of mind. For patients, it offers a path to recovery without the burden of debilitating side effects. As we continue to fight bacterial evolution, formulations like Amoxycillin Clavulanate & Lactic Acid Bacillus will remain at the forefront of the battle, ensuring health and wellness for all.
Contact Aingo Pharma today for PCD Franchise and Third-Party Manufacturing opportunities for Angoclav-625 LB and other premium formulations.
Contact Details:
Address: SCF-32, Ground Floor, Motor Market, Manimajra, Chandigarh, India
Phone No:+91-82880-84022
Email: aingopharma@gmail.com
Website: https://aingoph